Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12219327
Substituted isoindolines as PI3K-alpha inhibitors
granted -
US 12209085
RET inhibitors, pharmaceutical compositions and uses thereof
granted -
US 12202845
Ras inhibitors
granted -
US 12201617
HDAC6 inhibitors for treatment of metabolic disease and HFpEF
granted -
US 12186324
Imidazopiperazine inhibitors of transcription activating proteins
granted -
US 12187754
LpxC inhibitors and uses thereof
granted -
US 12186313
Pyridazinone compounds and their use as DAAO inhibitors
granted -
US 12187694
SLC26A3 inhibitors and use thereof
granted -
US 12187792
IL-4/IL-13 pathway inhibitors for enhanced efficacy in treating cancer
granted -
US 12187731
Compounds useful as inhibitors of ATR kinase
granted -
US 12187746
C26-linked rapamycin analogs as mTOR inhibitors
granted -
US 12171741
2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted -
US 12171760
Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors
granted -
US 12171765
Combination therapies using PRMT5 inhibitors for the treatment of cancer
granted -
US 12168023
Inhibitors of adenosine 5′-nucleotidase
granted -
US 12162877
Human dihydroorotate dehydrogenase (hDHODH) inhibitors and their use in targeting oncological diseases sensitive to pyrimidine starvation
granted -
US 12162838
Human plasma kallikrein inhibitors
granted -
US 12162818
Inhibitors of the n-terminal domain of the androgen receptor
granted -
US 12157891
Treatment of uveitis with endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitors
granted -
US 12156880
Heterocyclic RIP1 kinase inhibitors
granted -
US 12156879
Combining BACE1 inhibitors with mGluR agonists for Alzheimer's disease therapy
granted -
US 2024390317
COMBINATION TREATMENT AND/OR PREVENTION OF CARDIAC DISEASES IN NON-HUMAN MAMMALS COMPRISING ONE OR MORE SGLT-2 INHIBITORS AND PIMOBENDAN AND/OR TELMISARTAN
granted -
US 2024390332
Combination treatment and/or prevention of renal diseases and/or hypertension in non-human mammals comprising one or more SGLT-2 inhibitors and telmisartan
granted -
US 12152034
FGFR inhibitors and methods of making and using the same
granted